Rogério Lilenbaum
Rogério Lilenbaum publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.
- World rank
- #633,812 of 7,710,434 ranked researchers
- Rank in United States
- #216,393 of 1,627,098
- Works
- 139
- Citations
- 14k
- Citations per work
- 97.3
What does Rogério Lilenbaum research?
Rogério Lilenbaum's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11481.7%
- Medicine11481.7%
- Everything else1813.3%
- Life Sciences75.0%
- 1Pulmonary and Respiratory Medicine44% of their works
- 2Oncology31% of their works
- 3Molecular Biology5% of their works
- 4Pathology and Forensic Medicine2% of their works
- 5Hepatology2% of their works
- 6Epidemiology2% of their works
Research topics
Which keywords describe Rogério Lilenbaum's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Genomic Profiles.
- Immune Checkpoint Blockade
- Hepatocellular Carcinoma
- DNA
- Cetuximab
- Chemotherapy-Induced Peripheral Neuropathy
- Genomic Profiles
- CT Screening
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Lung Cancer
- Small-Cell Lung Cancer
- Taxanes
- KRAS Mutations
- Topoisomerases
- Liver Cancer
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Clinical Trials1562 topics
- Targeted Therapy1562 topics
- Chemotherapy1554 topics
- ALK Inhibitors951 topic
- EGFR Mutations951 topic
- CT Screening651 topic
- Lung Cancer651 topic
- Genomic Profiles611 topic
- Small-Cell Lung Cancer611 topic
- Chemotherapy-Induced Peripheral Neuropathy181 topic
- Taxanes181 topic
- Cetuximab161 topic
- KRAS Mutations161 topic
- DNA131 topic
- Topoisomerases131 topic
- Hepatocellular Carcinoma91 topic
- Liver Cancer91 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
Where does Rogério Lilenbaum work?
Rogério Lilenbaum's main affiliation in the publication record is Mount Sinai Medical Center, United States.
How many publications and citations does Rogério Lilenbaum have?
OpenAlex counts 139 works and 13,519 citations for Rogério Lilenbaum, an h-index of 41, ranking #633,812 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Rogério Lilenbaum
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rogério Lilenbaum. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.